Details for Patent: 9,388,159
✉ Email this page to a colleague
Which drugs does patent 9,388,159 protect, and when does it expire?
Patent 9,388,159 protects ERLEADA and is included in one NDA.
This patent has eighty-two patent family members in nineteen countries.
Summary for Patent: 9,388,159
Title: | Substituted diazaspiroalkanes as androgen receptor modulators |
Abstract: | This invention provides for compounds of the Formula II: ##STR00001## wherein A, B, Het, R.sub.1, R.sub.2 and R.sub.3 are as described herein. These compounds are androgen receptor modulators useful for the treatment of androgen receptor-associated conditions. |
Inventor(s): | Jung; Michael E. (Los Angeles, CA), Sawyers; Charles L. (New York, NY), Ouk; Samedy (Los Angeles, CA), Tran; Chris (New York, NY), Wongvipat; John (New York, NY) |
Assignee: | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA) |
Application Number: | 14/318,234 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,388,159 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Delivery; Dosage form; |
Drugs Protected by US Patent 9,388,159
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-001 | Feb 14, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-002 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,388,159
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2368550 | ⤷ Sign Up | 300993 | Netherlands | ⤷ Sign Up |
European Patent Office | 2368550 | ⤷ Sign Up | CA 2019 00029 | Denmark | ⤷ Sign Up |
European Patent Office | 2368550 | ⤷ Sign Up | 2019C/529 | Belgium | ⤷ Sign Up |
European Patent Office | 2368550 | ⤷ Sign Up | 122019000060 | Germany | ⤷ Sign Up |
European Patent Office | 2368550 | ⤷ Sign Up | LUC00123 | Luxembourg | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |